209 related articles for article (PubMed ID: 22251142)
1. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
Dong D; Wu B; Chow D; Hu M
Drug Metab Rev; 2012 May; 44(2):192-208. PubMed ID: 22251142
[TBL] [Abstract][Full Text] [Related]
2. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
Dong D; Wu B
Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
[TBL] [Abstract][Full Text] [Related]
3. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
Lewis DF; Ito Y
Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
[TBL] [Abstract][Full Text] [Related]
4. Designing better drugs: predicting cytochrome P450 metabolism.
de Groot MJ
Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
[TBL] [Abstract][Full Text] [Related]
5. Human CYPs involved in drug metabolism: structures, substrates and binding affinities.
Lewis DF; Ito Y
Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):661-74. PubMed ID: 20402561
[TBL] [Abstract][Full Text] [Related]
6. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
[TBL] [Abstract][Full Text] [Related]
7. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
Lewis DF; Jacobs MN; Dickins M
Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
[TBL] [Abstract][Full Text] [Related]
8. Prediction of drug-like molecular properties: modeling cytochrome p450 interactions.
Jalaie M; Arimoto R; Gifford E; Schefzick S; Waller CL
Methods Mol Biol; 2004; 275():449-520. PubMed ID: 15141126
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design.
Krajewski WW; Collins R; Holmberg-Schiavone L; Jones TA; Karlberg T; Mowbray SL
J Mol Biol; 2008 Jan; 375(1):217-28. PubMed ID: 18005987
[TBL] [Abstract][Full Text] [Related]
10. Conformational states of cytochrome P450cam revealed by trapping of synthetic molecular wires.
Hays AM; Dunn AR; Chiu R; Gray HB; Stout CD; Goodin DB
J Mol Biol; 2004 Nov; 344(2):455-69. PubMed ID: 15522298
[TBL] [Abstract][Full Text] [Related]
11. Crystal Structures of Drug-Metabolizing CYPs.
Estrada DF; Kumar A; Campomizzi CS; Jay N
Methods Mol Biol; 2021; 2342():171-192. PubMed ID: 34272695
[TBL] [Abstract][Full Text] [Related]
12. Structural modelling of the human drug-metabolizing cytochromes P450.
Lewis DF; Ito Y; Goldfarb PS
Curr Med Chem; 2006; 13(22):2645-52. PubMed ID: 17017916
[TBL] [Abstract][Full Text] [Related]
13. Use of density functional theory in drug metabolism studies.
Rydberg P; Jørgensen FS; Olsen L
Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):215-27. PubMed ID: 24295134
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and significance of inhibitory drug interactions involving cytochrome P450 enzymes (review).
Murray M
Int J Mol Med; 1999 Mar; 3(3):227-38. PubMed ID: 10028046
[TBL] [Abstract][Full Text] [Related]
15. Class-dependent sequence alignment strategy improves the structural and functional modeling of P450s.
Baudry J; Rupasinghe S; Schuler MA
Protein Eng Des Sel; 2006 Aug; 19(8):345-53. PubMed ID: 16777908
[TBL] [Abstract][Full Text] [Related]
16. Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.
Cupp-Vickery JR; Garcia C; Hofacre A; McGee-Estrada K
J Mol Biol; 2001 Aug; 311(1):101-10. PubMed ID: 11469860
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of cytochrome P450 MoxA from Nonomuraea recticatena (CYP105).
Yasutake Y; Imoto N; Fujii Y; Fujii T; Arisawa A; Tamura T
Biochem Biophys Res Commun; 2007 Oct; 361(4):876-82. PubMed ID: 17679139
[TBL] [Abstract][Full Text] [Related]
18. In silico predictive metabolism: a structural/electronic filter method.
Harris DL
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):43-8. PubMed ID: 14982147
[TBL] [Abstract][Full Text] [Related]
19. In silico methods for predicting ligand binding determinants of cytochromes P450.
de Groot MJ; Kirton SB; Sutcliffe MJ
Curr Top Med Chem; 2004; 4(16):1803-24. PubMed ID: 15579109
[TBL] [Abstract][Full Text] [Related]
20. Toward Computational Understanding of Molecular Recognition in the Human Metabolizing Cytochrome P450s.
Kontoyianni M; Lacy B
Curr Med Chem; 2018; 25(28):3353-3373. PubMed ID: 29484977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
